1-3 of 3
Margarita Bruno
Close
Sort by
Journal Articles

Clinically Discordant Indolent Lymphomas: A Subset of Indolent NHLs with a Less Favorable Prognosis and Propensity to Transform

Fernando Cabanillas, MD, Noridza Rivera, MD, Orestes Pavia, MD, Wandaly I. Pardo, MD, Margarita Bruno, MD
Journal: Blood
Blood (2015) 126 (23): 1497.
https://doi.org/10.1182/blood.V126.23.1497.1497
Published: 2015
Journal Articles

The Pretreatment Absolute Lymphocyte Count (ALC), but Not the Absolute Monocyte Count (AMC) or ALC/AMC Ratio, Is an Independent Prognostic Factor in Aggressive Non-Hodgkin Lymphoma (aNHL)

Noridza Rivera-Rodriguez, MD, Fernando Cabanillas, MD, Carlos Montalban, Jose Francisco Tomas, MD, María José Terol, MD, PhD, Armando López-Guillermo, MD, Wandaly I. Pardo, MD, Orestes A. Pavia, MD, Margarita Bruno, MD, Karen Janice Santiago, Pablo Guisado-Vasco, MD, PhD, Angel Ruedas, MD, Raquel de Oña, Silvia Solorzano, Ana Isabel Teruel, MD, Laura Garcia-Sanchis, Jordina Rovira, MD, Ivan Dlouhy
Journal: Blood
Blood (2012) 120 (21): 1596.
https://doi.org/10.1182/blood.V120.21.1596.1596
Published: 2012
Journal Articles

Phase I-II Study of Dose Dense PEG-Filgrastim and GM-CSF as Support for Dose Dense CHOP-R Front Line Therapy for Aggressive Non-Hodgkin's Lymphoma (NHL).

Maribel Cotto, MD, Fernando Cabanillas, MD, Idalia Liboy, MD, Ezequiel Rivera, MD, Orestes A. Pavia, MD, Margarita Bruno
Journal: Blood
Blood (2010) 116 (21): 2789.
https://doi.org/10.1182/blood.V116.21.2789.2789
Published: 2010